Neoplasms + Disorders of the Breast Flashcards

1
Q

Risk factors for breast cancer

A
  • Menarche before age 12
  • Old age of first full-term pregnancy, no pregnancies
  • Menopause after age 52
  • Breast mass- immobile, irregular
  • Nipple retraction, bloody nipple discharge
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MC type of breast cancer

A

Infiltrating Intraductal Carcinoma (IIC) 80%

  • Infiltrating lobular (10%) frequently bilateral
  • Paget’s disease of the nipple (1%) chronic eczematous itchy, scaling rash on the nipples and areola
  • Inflammatory breast cancer (2%) red swollen, warm and itchy breast often with nipple retraction and peau d’orange (NO LUMP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

When should mammo’s begin?

A

every 2 years from age 50-74

Every 2 years beginning at age 40 if increased risk factors – 10 years prior to the age the 1’st degree relative was diagnosed.

  • Clinical breast exam every 3 years in women age 20-39 years then annually after age 40
  • Breast self-exam monthly beginning at age 20 – immediately after menstruation on days 5-7 of the menstrual cycle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tx of breast cancer

A
  • Segmental mastectomy (lumpectomy) followed by breast irradiation in all patients and adjunctive chemotherapy in women with positive nodes stage I and stage II with tumors less than 4 cm in diameter
  • Anti-estrogen Tamoxifen is useful in tumors that are ER-positive – binds and blocks the estrogen receptor in the breast tissue
  • Aromatase inhibitors are useful in postmenopausal ER-positive patients with breast cancer – reduces the production of estrogen
  • Monoclonal AB treatment is useful in patients with HER2 positivity (Human Epidermal Growth Factor Receptor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What clinical triad is strongly indicative of cervical cancer extension to the pelvic wall?

A

Unilateral leg edema, sciatic pain, ureteral obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

abnormal vaginal bleeding, most commonly postmenopausal

A

80% present with these sx = Cervical cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MC type of cervical cancer

A
  • 80% are squamous cells and arise from the squamocolumnar junction of the cervix (transformational zone)
  • HPV is 99% of the reason for cervical cancer, types that cause cancer are 16,18,31 and 33. Especially types 16, 18
  • Associated with cigarette smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

RF of cervical cancer

A

Multiple sexual partners, early age at first intercourse, early first pregnancy, and HPV positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dx of cervical cancer

A

Friable, bleeding cervical lesion on exam

  • Biopsy of gross lesions and colposcopically directed biopsies are the definitive means of diagnosis
  • Majority of cases (80%) are invasive squamous cell types usually arising from the ectocervix
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tx of cervical cancer

A

Resect and/or chemotherapy and radiation

  • Stage 1: conservative, simple, or radical hysterectomy
  • Stage 2 +: chemo +/– radiation
  • 5-y survival– Stage 1: 85%-90% Stage 2: 65% Stage 3: 29% Stage 4: 21%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

At what age should your patient receive their first PAP regardless of sexual activity?

A

First PAP at the age of 21 regardless of sexual activity (no pap indicated prior to that)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

For women aged 21 to 29, all guidelines recommend only cytology screening every

A

3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

For women 30 years and older, combination of cytology + HPV testing is recommended every

A

Every 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Who should get annual cervical screenings?

A
  • Annual screening is recommended for any high-risk groups (HIV infection, immunosuppression, or in utero DES exposure) or women who have treated in the past for CIN 2, CIN 3, or cervical cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the ACOG recommendations for discontinuing papsmear

A
  • No cytology screening after total hysterectomy if surgery for benign condition. If surgery for CIN I, II, or III, then annually three times before discontinuing.
  • Discontinue screening at age 65 for women who have had adequate recent screening. Adequate screening is defined as three consecutive negative cytology tests or two consecutive negative HPV/Pap co-tests in the 10 years before stopping, with the most recent test within 5 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the PAP screening pathology report findings:

A
  • ASC-US: Atypical squamous cells of undetermined significance
  • LSIL: Low-grade squamous intraepithelial lesion, that is, mild dysplasia, CIN I
  • HSIL: High-grade squamous intraepithelial lesion, that is, moderate to severe dysplasia, CIN II-III, carcinoma in situ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which types of HPV have a high likelihood of leading to cervical cancer

A

HPV types 16, 18, and 31 are risk factors for cervical dysplasia, which can lead to cervical cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Women with negative cytology and HPV positive ⇒ both tests should be repeated in

A

12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Tx of ASC-US or LSIL, CIN-1

A
  • Reflex HPV
    • If positive and at least 25 years old – colposcopy
      • If negative or under 25 years old – retest in 1 year
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Tx of HSIL, CIN-2, CIN-3, CIS

A
  • Colposcopy
    • Outside cervix – LEEP or cryotherapy
    • Inside cervix – cone biopsy
    • Squamous cell carcinoma ⇒ Resect and/or chemotherapy and radiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When is the HPV vaccine recommended?

A
  • Females and males – HPV vaccine is recommended at 11 to 12 years. It can be administered starting at 9 years of age, and catch-up vaccination is recommended for females aged 13 to 26 years who have not been previously vaccinated or who have not completed the vaccine series.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Can pregnant women receive the HPV vaccine?

A

Not recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

males 22 to 26 years old, catch-up HPV vaccination is recommended if they are

A

men who have sex with men or immunocompromised (including HIV-infected males).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the dosing for the HPV vaccine if <15 yo

A
  • < 15 years old: administer a two- rather than a three-dose vaccine series. In such patients, the two doses are administered at least six months apart
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

> 15 years old: the HPV vaccine is administered in

A

three doses at 0, at 1 to 2 months, and at 6 months

Immunocompromised should also have 3 dose vaccine series

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

most common GYN malignancy and the fourth most common malignancy in women in the US

A

Endometrial cancer

27
Q

postmenopausal vaginal bleeding One-third of women with postmenopausal bleeding have

A

Endometrial cancer

28
Q

MC type of endometrial cancer

A

Adenocarcinoma

29
Q

Risk factors for endometrial cancer

A

Obesity, nulliparity, early menarche, late menopause, unopposed estrogen stimulation, hypertension, gallbladder disease, DM, prior ovarian, endometrial, or breast cancer

30
Q

Dx of endometrial cancer

A

Endometrial biopsy is the gold standard definitive diagnostic test

Endometrial biopsy is indicated in all postmenopausal women vaginal bleeding

31
Q

Tx of endometrial cancer

A

total hysterectomy and bilateral salpingo-oophorectomy, pelvic radiation therapy with or without chemotherapy for stage II or III cancer

32
Q

second most common type of GYN cancerin women (the first is endometrial cancer)

A

Ovarian cancer

33
Q

40-60 years of age, ascites, abdominal pain ⇒ 75% diagnosed at an advanced stage

A

Ovarian cancer

34
Q

What are protective factors and risk factors for ovarian cancer?

A
  • Protective factors for the risk of ovarian cancer include multiparty, OCP use, and breast-feeding
    • Use of oral contraceptives: 5 years of use decreases risk by 20%; 15 years by 50%
  • Risk factors: nulligravidity (or infertility), early menarche, late menopause, endometriosis
  • 90% are epithelial tumors ⇒ germ cell tumors are more common in patients < 10 years old
35
Q

Dx of ovarian cancer

A

Diagnose with transvaginal ultrasound then biopsy

  • Serum tumor marker CA-125BRCA1 gene is associated with 5% of cases
36
Q

Tx of ovarian cancer

A

Stage 1A or 1B—Surgical excision alone (abdominal hysterectomy and bilateral salpingo-oophorectomy)

  • Other stages—Surgical resection followed by adjuvant chemotherapy or radiation
  • Monitor CA-125 afterward to assess disease progress
37
Q

What are the known risk factors for vulvar/vaginal carcinoma?

A

HPV infection, Smoking, Coexisting cervical carcinoma, In utero exposure to DES

38
Q

MC type of vaginal/vulvar neoplasms

A

Squamous cell represents 95% caused by HPV

  • Adenocarcinoma caused by DES exposure
39
Q

MC location of vaginal/vulvar neoplasms

A
  • Most common location of vaginal carcinoma is the upper one-third of the posterior vaginal wall
40
Q

Sx and Tx of vaginal/vulvar neoplasms

A

Usually presents as changes in menstrual period and/or abnormal vaginal bleeding

TX: with radiation therapy

41
Q
  • Vaginal pruritus is the most common presentation (70% will present with this symptom) of this type of cancer
A

Vulvar cancer

42
Q

MCC of vulvar cancer

A
  • 90% are squamous cell cancers and melanoma. Risks include HPV subtypes 16, 18, and 31 – pruritic black lesions`
43
Q

Tx of vulvar cancer

A

Vulvectomy and lymph node dissection

Paget’s – pruritic red lesions

TX: Local resection

44
Q

Dx of vulvar cancer

A

Application of acetic acid or staining with toluidine blue may help direct optimal biopsy location

45
Q

32-year-old lactating female with breast pain, swelling, fever, chills, and a fluctuant mass of her left breast. The area directly above the lesion is warm, erythematous and tender to touch.

A

Breast abscess

46
Q

Should a patient with a breast abscess continue to breastfeed on the affected side?

A

Women should be encouraged to continue breastfeeding following breast infection, even in the setting of incision and drainage

47
Q

MCC of breast abscess

A

Staphylococcus aureus is the most common cause

A progression from mastitis - symptoms are the same with the addition of localized mass and systemic signs of infection

48
Q

Tx of breast abscess

A

I&D and anti-staph antibiotics

  • Regimen: Nafcillin/oxacillin IV or cefazolin PLUS metronidazole
  • Alternative is Vancomycin
  • Women should be encouraged to continue breastfeeding following breast infection, even in the setting of incision and drainage
49
Q

a 27-year-old female with a painless mass in the left breast. She discovered this mass three months ago while showering and reports it has been unchanged since that time. Her last menstrual period was 10 days ago. There is no family history of breast cancer. On physical exam, you palpate a 3 cm, firm, non-tender mass in the upper lateral quadrant of the left breast. The mass is smooth, well-circumscribed, and mobile. There are no skin changes, nipple discharge, or axillary lymphadenopathy

A

Breast fibroadenoma

50
Q

Most common type of noncancerous breast tumor that most often occurs in young women

A

Breast fibroadenoma

51
Q

Sx of breast fibroadenoma

A
  • small, firm, usually painless, well-circumscribed, completely round, and freely mobile breast mass
  • The classic description with respect to consistency is “rubbery.”
52
Q

Dx of breast fibroadenoma

A

Diagnostic mammogram with ultrasound

  • If indeterminant, fine-needle aspiration of the mass with pathology
    • In women younger than 25 years, fibroadenomatous mass should be biopsied
53
Q

Tx of breast fibroadenoma

A

After the establishment of fibrocystic breast disease recommended treatments include:

  • Avoiding trauma and by wearing a bra with adequate support
  • Combined oral contraceptive agents limit the severity of the cyclical changes in the breast tissue
  • Many patients report relief of symptoms after abstinence from coffee, tea, and chocolate

DONE

54
Q

42-year-old woman with breast masses that changes in size, especially during her menstrual cycles. These masses are usually painful and pain radiates into the axillae. She reports that her breasts often feel full and heavy. Occasionally she has a small amount of greenish-brown nipple discharge. An ultrasound exam shows cystic masses within the breasts

A

Fibrocystic breast disease

55
Q

benign (noncancerous) condition in which the breasts feel lumpy

A

Fibrocystic breast disease

56
Q

Dx of fibrocystic breast dz

A

Diagnosis is by breast cyst aspiration supplemented by ultrasound and/or mammogram

  • Straw-colored fluid with no blood
57
Q

Tx of fibrocystic breast dz

A

Treat with NSAIDs, heat or ice, support bra, decrease caffeine, fat chocolate

  • Women should be encouraged to perform monthly self-breast exams one week after period when cysts are at their smallest
  • Oral contraceptives with low estrogenic activity and potent progestin, medroxyprogesterone acetate
  • Most resolve spontaneously ⇒ +/- fine needle aspiration for removal of fluid
58
Q

Patient with infectious mastitis present as → a breastfeeding woman 3 weeks postpartum complaining of a painful area of the breast that is reddened and warm. The patient feels very fatigued with a fever generally > 101 ° F and chills. She reports a burning pain present constantly or at times only while breastfeeding. On exam, the patient appears ill. Breast examination shows an erythematous right breast with a palpable mass, induration, erythema, and tenderness to palpation.

A

Mastitis

59
Q

What is the most common causative organism in mastitis, breast infection, or breast abscess?

A

Staph aureus

60
Q

A regional infection of the breast from skin flora or oral flora of breastfeeding baby – organisms enter erosion or cracked nipple; the main cause is clogged milk ducts

A

Mastitis

61
Q

Sx of mastitis

A
  • Unilateral erythema, tenderness, usually only one quadrant of the breast affected, fever and chills
  • Congestive (bilateral) vs. Infectious (unilateral)
    • Usually caused by S.aureus
62
Q

Dx of mastitis

A

Clinical - if an abscess is suspected and ultrasound may be warranted

63
Q

Tx of mastitis

A

warm compresses to the breast and analgesics

  • If infectious, treat with dicloxacillin, cephalexin or erythromycin for staphylococcus aureus alternate is clindamycin
  • Continue to breastfeed on the affected side along with warm heat 4 times per day